Search
Company
Back
Business Management
Back
Sustainability
Back
Products
Back
Diagnostics
Back
Life Science
Back
Academy
Back
Knowledge Centre
Back
Career
Back
Menu
Headquarters
Sysmex Group Companies
Select your local website
OSNA in gastric cancer
Informed decisions for therapy depend on accurate staging
- Precise lymph node analysis providing more accurate staging
- Easier therapy decisions thanks to reliable diagnostic information
- CE-marked for gastric, colon and breast cancer
- Highly productive analyses from multi-cancer application
Using the sentinel concept often reduces the need for lymphadenectomy. This is true for several different types of cancer, including gastric cancer. In early gastric cancer, lymph node metastasis occurs in some 10-16% of cases1, so patients could benefit from a less invasive surgery. The intraoperative OSNA result can support your immediate decision on further lymph node dissection.
OSNA – benefit from intelligent diagnostics
- Enables immediate and fully-informed decisions during surgical procedures
- Confidence not to overlook metastases by analysing the entire lymph node
- Standardised and observer-independent
Contact
You have a question and would like to get in touch with our experts? We look forward to receiving your enquiry.
Sysmex UK LTD
Sysmex House
Garamonde Drive
Wymbush
Milton Keynes
MK8 8DF
0333 320 3460
